136 related articles for article (PubMed ID: 12173305)
1. Increased microchimeric CD4+ T lymphocytes in peripheral blood from women with systemic sclerosis.
Artlett CM; Cox LA; Ramos RC; Dennis TN; Fortunato RA; Hummers LK; Jimenez SA; Smith JB
Clin Immunol; 2002 Jun; 103(3 Pt 1):303-8. PubMed ID: 12173305
[TBL] [Abstract][Full Text] [Related]
2. Alterations of mononuclear inflammatory cells, CD4/CD8+ T cells, interleukin 1beta, and tumour necrosis factor alpha in the bronchoalveolar lavage fluid, peripheral blood, and skin of patients with systemic sclerosis.
Hussein MR; Hassan HI; Hofny ER; Elkholy M; Fatehy NA; Abd Elmoniem AE; Ezz El-Din AM; Afifi OA; Rashed HG
J Clin Pathol; 2005 Feb; 58(2):178-84. PubMed ID: 15677539
[TBL] [Abstract][Full Text] [Related]
3. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
Fuschiotti P; Medsger TA; Morel PA
Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
[TBL] [Abstract][Full Text] [Related]
4. T cell repertoire in patients with stable scleroderma.
Tiev KP; Abriol J; Burland MC; Antonelli D; Klatzmann D; Cabane J; Boyer O
Clin Exp Immunol; 2005 Feb; 139(2):348-54. PubMed ID: 15654834
[TBL] [Abstract][Full Text] [Related]
5. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis.
Parel Y; Aurrand-Lions M; Scheja A; Dayer JM; Roosnek E; Chizzolini C
Arthritis Rheum; 2007 Oct; 56(10):3459-67. PubMed ID: 17907151
[TBL] [Abstract][Full Text] [Related]
6. T and NK Cell Phenotypic Abnormalities in Systemic Sclerosis: a Cohort Study and a Comprehensive Literature Review.
Almeida I; Silva SV; Fonseca AR; Silva I; Vasconcelos C; Lima M
Clin Rev Allergy Immunol; 2015 Dec; 49(3):347-69. PubMed ID: 26445774
[TBL] [Abstract][Full Text] [Related]
7. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
Sawaya HH; Jimenez SA; Artlett CM
Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
[TBL] [Abstract][Full Text] [Related]
8. Increased frequency of interleukin 4 producing CD4+ and CD8+ cells in peripheral blood from patients with systemic sclerosis.
Tsuji-Yamada J; Nakazawa M; Minami M; Sasaki T
J Rheumatol; 2001 Jun; 28(6):1252-8. PubMed ID: 11409116
[TBL] [Abstract][Full Text] [Related]
9. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
[TBL] [Abstract][Full Text] [Related]
10. Reduction of regulatory T cells in skin lesions but not in peripheral blood of patients with systemic scleroderma.
Klein S; Kretz CC; Ruland V; Stumpf C; Haust M; Hartschuh W; Hartmann M; Enk A; Suri-Payer E; Oberle N; Krammer PH; Kuhn A
Ann Rheum Dis; 2011 Aug; 70(8):1475-81. PubMed ID: 21097800
[TBL] [Abstract][Full Text] [Related]
11. Alteration of Th17 and Treg cell subpopulations co-exist in patients affected with systemic sclerosis.
Fenoglio D; Battaglia F; Parodi A; Stringara S; Negrini S; Panico N; Rizzi M; Kalli F; Conteduca G; Ghio M; De Palma R; Indiveri F; Filaci G
Clin Immunol; 2011 Jun; 139(3):249-57. PubMed ID: 21419712
[TBL] [Abstract][Full Text] [Related]
12. Soluble serum interleukin 2 receptors in patients with systemic sclerosis.
Steen VD; Engel EE; Charley MR; Medsger TA
J Rheumatol; 1996 Apr; 23(4):646-9. PubMed ID: 8730120
[TBL] [Abstract][Full Text] [Related]
13. Alpha4beta1 and alpha4beta7 CD4 T cell numbers increase and CLA CD4 T cell numbers decrease in systemic sclerosis.
Scala E; Paganelli R; Sampogna F; Abeni D; Colonna L; De Pità O; Puddu P; Russo G
Clin Exp Immunol; 2005 Mar; 139(3):551-7. PubMed ID: 15730402
[TBL] [Abstract][Full Text] [Related]
14. Detection of cellular microchimerism of male or female origin in systemic sclerosis patients by polymerase chain reaction analysis of HLA-Cw antigens.
Artlett CM; Cox LA; Jimenez SA
Arthritis Rheum; 2000 May; 43(5):1062-7. PubMed ID: 10817560
[TBL] [Abstract][Full Text] [Related]
15. Contribution of CD8+ T cells to inflammatory cytokine production in systemic sclerosis (SSc).
Klein M; Schmalzing M; Almanzar G; Benoit S; Hamm H; Tony HP; Goebeler M; Prelog M
Autoimmunity; 2016 Dec; 49(8):532-546. PubMed ID: 27560622
[TBL] [Abstract][Full Text] [Related]
16. [Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].
Ma XB; Zhang XW; Jia RL; Gao Y; Liu HJ; Liu YF; Li YN
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):721-727. PubMed ID: 34393235
[TBL] [Abstract][Full Text] [Related]
17. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
[TBL] [Abstract][Full Text] [Related]
18. Cellular microchimerism as a lifelong physiologic status in parous women: an immunologic basis for its amplification in patients with systemic sclerosis.
Burastero SE; Galbiati S; Vassallo A; Sabbadini MG; Bellone M; Marchionni L; Smid M; Ferrero E; Ferrari A; Ferrari M; Cremonesi L
Arthritis Rheum; 2003 Apr; 48(4):1109-16. PubMed ID: 12687555
[TBL] [Abstract][Full Text] [Related]
19. Increased CD8+ T cell apoptosis in scleroderma is associated with low levels of NF-kappa B.
Kessel A; Rosner I; Rozenbaum M; Zisman D; Sagiv A; Shmuel Z; Sabo E; Toubi E
J Clin Immunol; 2004 Jan; 24(1):30-6. PubMed ID: 14997031
[TBL] [Abstract][Full Text] [Related]
20. DNA demethylation of CD40l in CD4+ T cells from women with systemic sclerosis: a possible explanation for female susceptibility.
Lian X; Xiao R; Hu X; Kanekura T; Jiang H; Li Y; Wang Y; Yang Y; Zhao M; Lu Q
Arthritis Rheum; 2012 Jul; 64(7):2338-45. PubMed ID: 22231486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]